THV01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for THV01, covering 2019-04-11 to 2019-04-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART). [Phase 1, Phase 2]